fbpx
Tag Pneumonia
Sketchbook MD LITFL 340

SARS-CoV-2 phenotypes

Some experts divide patients in two separate phenotypes: The “L” phenotype characterized by a hypoxemic failure and “low elastance” lungs (high compliance) and the “H” phenotype with “high elastance and recoil” lungs (lower compliance).
Ultrasound LIBRARY 340 1

Pneumonia Case 003

A 40 year old man presented with high fever, tachycardia and vomiting. You search for a source of infection; this is his chest x-ray.
Ultrasound LIBRARY 340 1

Pneumonia Case 002

This young man presents with high fevers and shortness of breath. He also complains of chest discomfort and an odd feeling in his neck. He is febrile, tachycardic, tachypneoic and hypoxic.
Ultrasound cases top 100 340

Pneumonia Case 001

This patient presented with right upper quadrant pain and a fever. The clinical suspicion was cholecystitis. What does the ultrasound show?
CCC Critical Care compendium 340

Community Acquired Pneumonia

Community Acquired Pneumonia: Streptococcus pneumonia (most common organism); other causes: Mycoplasma pneumoniae, Chlamydophila pneumoniae and Legionella, Haemophilus influenzae (in COPD)
CCC Critical Care compendium 340

Cryptogenic Organising Pneumonia

Cryptogenic Organising Pneumonia (COP) is also known as bronchiolitis obliterans organising pneumonia (BOOP); not the same as bronchiolitis obliterans; the rapidly progressive form has a very poor prognosis
CCC Critical Care compendium 340

Pneumonia in Pregnancy

Pneumonia in Pregnancy: 2 patients; treatment dependent on stage of pregnancy (first trimester: avoidance of teratogenicity, third trimester: prevention of pre-term labour) signs of severe sepsis may be masked by normal pregnancy changes
CCC Critical Care compendium 340

Nosocomial Pneumonia

Nosocomial or hospital-acquired pneumonia (HAP) is defined as pneumonia that is not incubating at the time of admission to hospital and develops in a patient hospitalised for >48 hours.
CCC Critical Care compendium 340

Pneumonia in the Immunocompromised

The numbers of immunocompromised patients is increasing c/o improved solid-organ and haemopoietic transplants and the expanded use of immunomodulatory therapies. Pulmonary infections = most frequent complication with high mortality